BioCardia Advances Heart Failure Therapy | Business and Finance News

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded20 Aug 2026

Publisherfeeds.acast.com ↗

Handlerec:20071493

Show notes

BioCardia is on a fast track to revolutionize heart failure treatment, with major regulatory wins in both Japan and the U.S. The PMDA has endorsed CARDiAmp trial data and outlined clear next steps for approval, while the FDA now sees potential for market clearance based on their ongoing trial — a significant shift from past standards. Their minimally invasive HELIX catheter also received strong feedback. With a patient-focused, cell-based approach and expanding clinical infrastructure, BioCardia is positioning itself to deliver life-changing therapies to those with limited options — especially in Japan where demand is urgent. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/df998047a39668af

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.